The therapeutic approaches to T1D have drastically evolved since results of the Diabetes Control and Complications Trial (DCCT) confirmed the importance of intensive insulin therapy via multiple daily injections to achieve tight blood glucose control in1994.9 This discovery led to the development and introduction of insulin pumps and glucose monitoring sensors. The gene discussed is INS; the disease is type 1 diabetes mellitus.